Dr. Ulrich Steidl Appointed Director of Montefiore Einstein Comprehensive Cancer Center, Enhancing Cancer Research Leadership
Dr. Ulrich Steidl has been appointed as the director of the Montefiore Einstein Comprehensive Cancer Center (MECCC) and vice president of cancer medicine at Montefiore Einstein. This appointment marks a significant leadership change for the National Cancer Institute-designated center located in the Bronx, New York. Dr. Steidl, who has been with the institution since 2008, has played a pivotal role in advancing translational research and clinical applications in cancer treatment. His research focuses on the biology of blood cancers, particularly the characterization of pre-leukemic stem cells and their progression to leukemic stem cells. Dr. Steidl's work has been instrumental in understanding myelodysplastic syndrome (MDS) and its evolution into acute myeloid leukemia (AML), offering new therapeutic targets. His leadership is expected to further MECCC's mission of integrating scientific excellence with community-centered cancer care. 
